FOLH1 and metastatic prostate carcinoma: In 2020, the same group reported a useful mouse model of human metastatic prostate cancer by injecting C4-2 cells expressing firefly luciferase into the left ventricle of NSG mice, which was then used to evaluate the effectiveness of 225Ac-PSMA-617 at various disease stages [100].